Skip to content
DeepHealth Brain

Population Health

Neuro Suite

Standardize and automate neuroimaging analysis for WMH detection and brain volumetric quantification, leveraging quantitative measurements and normative data to deliver actionable insights for consistent, confident clinical decision-making at scale.

Discover key benefits

dash-speed

Standardized clinical excellence

Reduces interobserver variability with precise quantitative & objective measurements

time-speed

Streamlined
workflows

Eliminates time-consuming work with automated measurement, segmentation and reporting

goal-arrow

Diagnostic confidence

With automated WMH detection and atrophy quantification, providing longitudinal tracking to support early diagnosis

cost

Optimized performance at scale

Smooth integration with existing systems, delivering standardization with a unified clinical and operational experience

With a modular design to meet your unique clinical needs

cloud-outline

Cloud-native, accessible from anywhere

cogwheel-time

Automated & standardized reporting

FreeSurfer

Incorporates FreeSurfer

Icon_Brain Exam Top-white

Brain Health

Provides automatic localization of WMH regions and segmentation of the boundaries for accurate measurements.

Book a demo
Brain Health

Provides automated segmentation and objective assessment of total WMH volume, lesion count, and anatomical distribution.

Distinct color-coding for periventricular, deep white matter, juxtacortical, and infratentorial regions overlays on FLAIR images, enabling immediate visual assessment of lesion distribution patterns critical for differential diagnosis support.

Tracks progression when prior exams are available, classifies lesions as new, enlarging, stable, or shrinking, and generates automatic graphs of WMH volume changes.

brain-age

Brain Age

Enables automated objective quantification of brain atrophy, brain structure.

Book a demo
Brain Age

Provides automated segmentation of brain structure and accurate assessment of changes in volume.

Color-coded anatomical overlays on standard PACS viewers enable immediate visual assessment of brain structures.

Delivers quantitative measurements of region volume for comparison to prior exams and normative age- and sex-matched databases with percentile rankings that identify deviations from expectations.

Looking for the right solution? Schedule your demo.

Book a demo
Join us at the next event

RSNA 2025

Nov 30 - Dec 3, 2025
Chicago, US
Book a meeting
Dr. Mario Muto

"Using DeepHealth's Neuro Suite of products enables us to provide our clinicians with valuable objective information derived from our MRI scans.

Comparing the patient's results to a non-biased reference population makes it easier for clinicians to give patients insights into their atrophy development."

Dr. Mario Muto

Director Diagnostics and Interventional Neuroradiology
Caradelli Hospital, Naples

Dr. Howard Berger

"During our MDT meetings, we always pull up the report from DeepHealth's Neuro Suite of products and use it as extra information to come to a joint decision on the best diagnosis and clinical management of the patient."

Prof. Meike Vernooij

Population Imaging, Erasmus MC Rotterdam

Keeping the patient at the center is our primary goal

Professors Giovanni Capobianco and Marco Guazzaroni from ASL Roma 2, the Regional Health Authority of Rome worked with DeepHealth's AI-powered solution to segment the brain and prevent the progression and worsening of mild cognitive impairments through a collaborative multi-disciplinary approach.

Book a demo
CT scan

Transforming population health with AI-powered diagnostic screening programs

Explore our vision

Could healthcare begin before illness ever shows up? Rather than waiting for patients to experience symptoms, what if care started with prevention, early detection, and access to critical diagnostic tools?

Finding and treating diseases, like cancer, at earlier stages increases survival rates.1 Screening healthy people helps make early detection more possible. By expanding screening for a range of diseases, more people have the chance to stay healthy longer—and this shift has the potential to significantly transform population health.

Population Health Suite of Solutions

Orchestrate and scale high-volume cancer screening and disease assessment programs.

Find out more

References:
1) American Cancer Society. Breast Cancer Screening Guidelines, December 2023. Available on the https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html. (Accessed July 16, 2025)

Disclaimers: Neuro Suite is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us